Mechanistically, LIMK1 and CDK5 synergistically phosphorylate β‐catenin at S191, enhancing its phosphorylation and interaction with Nucleoporin 93, resulting in β‐catenin nuclear translocation and activation of key pathways in cancer metastasis. Here, CDK5 is linked to cancer.